Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02029703 · ClinicalTrials.gov registry record · NA
Optimization of Synvisc-One for Knee OA
A NA study, sponsored by Elaine Husni.
- Terminated
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT02029703 is a NA study that was terminated before completion, run by Elaine Husni. The registered enrollment target is 42 participants.
The verdict
NCT02029703, a NA study, was terminated before completion, sponsored by Elaine Husni.
- TERMINATED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The study hypothesis is that the use of Synvisc-One will improve physical therapy compliance and performance, resulting in improved knee function and pain when compared to a group that receives a sham injection (an injection that does not have medicine) only before a standardized physical therapy regimen over 10 weeks.
Interventions
- OTHER Sham Injection
- DEVICE Synvisc-One Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02029703
The ClinicalTrials.gov registry entry for NCT02029703 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Elaine Husni, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Injection is the first listed.
NCT02029703 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02029703 about?
NCT02029703 is a clinical study titled "Optimization of Synvisc-One for Knee OA". The study hypothesis is that the use of Synvisc-One will improve physical therapy compliance and performance, resulting in improved knee function and pain when compared to a group that receives a sham injection (an injection that does not have medicine) only before a standardized physical therapy re...
What is the current status of trial NCT02029703?
This trial is currently terminated. It is a NA study. The enrollment target is 42 participants. The study started on 2012-08. Estimated completion is 2015-11.
What interventions are being tested in trial NCT02029703?
The interventions under investigation include: Sham Injection (OTHER), Synvisc-One Injection (DEVICE).
Who is sponsoring clinical trial NCT02029703?
This trial is sponsored by Elaine Husni, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.